Schedule 13D ownership disclosure
Supernus Pharmaceuticals Inc
Security class unavailable · CUSIP: 868459108
Event date: 2015-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-15-000323
- Form type
- SC 13D
- Filer
- Abingworth Management LTD
- CIK
- CIK 1291892
- Filed
- Mar 26, 2015
- Reporting period
- Mar 17, 2015
- Description
- Schedule 13D beneficial ownership